3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cotransplantation of mesenchymal stem cells and endothelial progenitor cells for treating steroid‐induced osteonecrosis of the femoral head

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Steroid‐induced osteonecrosis of the femoral head (ONFH) is characterized by decreased osteogenesis, angiogenesis, and increased adipogenesis. While bone tissue engineering has been widely investigated to treat ONFH, its therapeutic effects remain unsatisfactory. Therefore, further studies are required to determine optimal osteogenesis, angiogenesis and adipogenesis in the necrotic area of the femoral head. In our study, we developed a carboxymethyl chitosan/alginate/bone marrow mesenchymal stem cell/endothelial progenitor cell (CMC/ALG/BMSC/EPC) composite implant, and evaluated its ability to repair steroid‐induced ONFH. Our in vitro studies showed that BMSC and EPC coculture displayed enhanced osteogenic and angiogenic differentiation. When compared with single BMSC cultures, adipogenic differentiation in coculture systems was reduced. We also fabricated a three‐dimensional (3D) CMC/ALG scaffold for loading cells, using a lyophilization approach, and confirmed its good cell compatibility characteristics, that is, high porosity, low cytotoxicity and favorable cell adhesion. 3D coculture of BMSCs and EPCs also promoted secretion of osteogenic and angiogenic factors. Then, we established an rabbit model of steroid‐induced ONFH. The CMC/ALG/BMSC/EPC composite implant was transplanted into the bone tunnel of the rabbit femoral head after core decompression (CD) surgery. Twelve weeks later, radiographical and histological analyses revealed CMC/ALG/BMSC/EPC composite implants had facilitated the repair of steroid‐induced ONFH, by promoting osteogenesis and angiogenesis, and reducing adipogenesis when compared with CD, CMC/ALG, CMC/ALG/BMSC and CMC/ALG/EPC groups. Thus, our data show that cotransplantation of BMSCs and EPCs in 3D scaffolds is beneficial in treating steroid‐induced ONFH.

          Abstract

          Bone marrow mesenchymal stem cell (BMSCs) and endothelial progenitor cell (EPCs) isolated from the tibia medullary cavity of rabbits were seeded in the carboxymethyl chitosan (CMC)/alginate (ALG) scaffold to construct the CMC/ALG/BMSCs/EPCs composite implant. Then, the composite implant was transplanted into the necrotic femoral head induced by lipopolysaccharide (LPS) and methylprednisolone (MPS). Repair effects of BMSCs/EPCs on steroid‐induced osteonecrosis of the femoral head (ONFH) were confirmed by increased osteogenesis and angiogenesis and decreased adipogenesis.

          Related collections

          Most cited references62

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Mesenchymal Stem Cells for Regenerative Medicine

          In recent decades, the biomedical applications of mesenchymal stem cells (MSCs) have attracted increasing attention. MSCs are easily extracted from the bone marrow, fat, and synovium, and differentiate into various cell lineages according to the requirements of specific biomedical applications. As MSCs do not express significant histocompatibility complexes and immune stimulating molecules, they are not detected by immune surveillance and do not lead to graft rejection after transplantation. These properties make them competent biomedical candidates, especially in tissue engineering. We present a brief overview of MSC extraction methods and subsequent potential for differentiation, and a comprehensive overview of their preclinical and clinical applications in regenerative medicine, and discuss future challenges.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Non-traumatic avascular necrosis of the femoral head.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Mesenchymal Stem Cells: Cell Fate Decision to Osteoblast or Adipocyte and Application in Osteoporosis Treatment

              Osteoporosis is a progressive skeletal disease characterized by decreased bone mass and degraded bone microstructure, which leads to increased bone fragility and risks of bone fracture. Osteoporosis is generally age related and has become a major disease of the world. Uncovering the molecular mechanisms underlying osteoporosis and developing effective prevention and therapy methods has great significance for human health. Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into osteoblasts, adipocytes, or chondrocytes, and have become the favorite source of cell-based therapy. Evidence shows that during osteoporosis, a shift of the cell differentiation of MSCs to adipocytes rather than osteoblasts partly contributes to osteoporosis. Thus, uncovering the molecular mechanisms of the osteoblast or adipocyte differentiation of MSCs will provide more understanding of MSCs and perhaps new methods of osteoporosis treatment. The MSCs have been applied to both preclinical and clinical studies in osteoporosis treatment. Here, we review the recent advances in understanding the molecular mechanisms regulating osteoblast differentiation and adipocyte differentiation of MSCs and highlight the therapeutic application studies of MSCs in osteoporosis treatment. This will provide researchers with new insights into the development and treatment of osteoporosis.
                Bookmark

                Author and article information

                Contributors
                jiasongguo@aliyun.com
                zhulixin1966@163.com
                Journal
                Stem Cells Transl Med
                Stem Cells Transl Med
                10.1002/(ISSN)2157-6580
                SCT3
                Stem Cells Translational Medicine
                John Wiley & Sons, Inc. (Hoboken, USA )
                2157-6564
                2157-6580
                13 January 2021
                May 2021
                : 10
                : 5 ( doiID: 10.1002/sct3.v10.5 )
                : 781-796
                Affiliations
                [ 1 ] Department of Spinal Surgery, Orthopedic Medical Center Zhujiang Hospital, Southern Medical University Guangzhou People's Republic of China
                [ 2 ] Department of Histology and Embryology Southern Medical University Guangzhou People's Republic of China
                [ 3 ] Key Laboratory of Tissue Construction and Detection of Guangdong Province Guangzhou People's Republic of China
                [ 4 ] Institute of Bone Biology Academy of Orthopaedics, Guangdong Province Guangzhou People's Republic of China
                Author notes
                [*] [* ] Correspondence

                Jiasong Guo, PhD, Department of Histology and Embryology, Southern Medical University, Guangzhou 510515, People's Republic of China.

                Email: jiasongguo@ 123456aliyun.com

                Lixin Zhu, MD, Department of Spinal Surgery, Orthopedic Medical Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, People's Republic of China.

                Email: zhulixin1966@ 123456163.com

                Author information
                https://orcid.org/0000-0003-3055-3063
                Article
                SCT312885
                10.1002/sctm.20-0346
                8046137
                33438370
                3cb488e1-37f4-4bf4-9f48-5dab3d7c13b9
                © 2021 The Authors. stem cells translational medicine published by Wiley Periodicals LLC on behalf of AlphaMed Press

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 14 November 2020
                : 25 July 2020
                : 06 December 2020
                Page count
                Figures: 7, Tables: 1, Pages: 16, Words: 9298
                Funding
                Funded by: Natural Science Foundation of Guangdong Province , open-funder-registry 10.13039/501100003453;
                Award ID: 2017A030312009
                Award ID: 2017A030313111
                Funded by: National Natural Science Foundation of China , open-funder-registry 10.13039/501100001809;
                Award ID: 81974329
                Award ID: 81672140
                Categories
                Tissue Engineering and Regenerative Medicine
                Tissue Engineering and Regenerative Medicine
                Custom metadata
                2.0
                May 2021
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.2 mode:remove_FC converted:14.04.2021

                adipogenesis,angiogenesis,bone marrow mesenchymal stem cells,endothelial progenitor cells,osteogenesis,osteonecrosis of the femoral head

                Comments

                Comment on this article